A functional assay in yeast for the human estrogen receptor displays wild-type and variant estrogen receptor messenger RNAs present in breast carcinoma

Cancer Research

Volumn 57, Issue 16, 1997, Pages 3478-3485

  Van Dijk, Mariska A J ^a   Floore, Arno N ^a   Kloppenborg, Kim I M ^a   Van't Veer, Laura J ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; MESSENGER RNA; TAMOXIFEN;

ALTERNATIVE RNA SPLICING; ARTICLE; BREAST CARCINOMA; CELL STRAIN MCF 7; DNA SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SACCHAROMYCES CEREVISIAE; TUMOR BIOPSY; YEAST;

BIOLOGICAL ASSAY; BREAST NEOPLASMS; DNA, COMPLEMENTARY; DNA, NEOPLASM; FEMALE; GENETIC VECTORS; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM PROTEINS; PHENOTYPE; POLYMERASE CHAIN REACTION; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RNA, MESSENGER; SACCHAROMYCES CEREVISIAE; TUMOR CELLS, CULTURED;

EID: 0030860502     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Gronemeyer, H. Transcription activation by estrogen and progesterone receptors. Annu. Rev. Genet., 25: 89-123, 1991.
2. Beato, M. Gene regulation by steroid hormones. Cell, 56: 335-344, 1989.
3. Evans, R. M. The steroid and thyroid hormone receptor superfamily. Science (Washington DC), 240: 889-895, 1988.
4. Green, S., and Chambon, P. The oestrogen receptor: from perception to mechanism. In: M. M. Parker (ed.), Nuclear Hormone Receptors, pp. 15-38. Orlando: Academic Press, 1991.
5. Tsai, M. J., and O'Mally, B. W. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem., 63: 451-486, 1994.
6. Ham, J., and Parker, M. G. Regulation of gene expression by steroid hormones. Curr. Opin. Cell. Biol., 1: 503-511, 1989.
7. King, R. J. B. A discussion of the roles of estrogen and progestin in human mammary carcinogenesis. J. Steroid Biochem. Mol. Biol., 39: 811-818, 1991.
8. Allegra, J. C., Lippman, M. E., Thompson, E. B., Simon, R., Barlock, A., Huff, K. K., Do, H. M., Aitkin, S. C., and Warren, R. Estrogen receptor status: an important variable in predicting response to endocrine therapy in metastatic breast cancer. Eur. J. Cancer, 16: 323-331, 1980.
9. Jaiyesimi, I. A., Buzdar, A. U., Decker, D. A., and Hortobagyi, G. N. Use of tamoxifen for breast cancer: twenty-eight years later. J. Clin. Oncol., 13: 513-529, 1995.
10. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immunetherapy: 133 randomized trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet, 339: 1-15, 71-85, 1992.
11. Saez, R. A., McGuire, W. L., and Clark, G. M. Prognostic factors in breast cancer. Semin. Surg. Oncol., 5: 102-110, 1989.
12. McGuire, W. L., Chamness, G. C., and Fuqua, S. A. W. Estrogen receptor variants in clinical breast cancer. Mol. Endocrinol., 5: 1571-1577, 1991.
13. Fernö. M., Andersson, C., Fallenius, G., and Idvall, I. Oestrogen receptor analysis of paraffin sections and cytosol samples of primary breast cancer in relation to outcome after adjuvant tamoxifen treatment. Acta Oncol., 35: 17-22, 1996.
14. Langan-Fahey, S. M., Tormey. D. C., and Jordan, V. C. Tamoxifen metabolites in patients on long-term adjuvant therapy for breast cancer. Eur. J. Cancer, 26: 883-888, 1990.
15. Wiebe, V. J., Osborne, C. K., McGuire, W. L., and DeGregorio, M. W. Identification of estrogenic tamoxifen metabolite(s) in tamoxifen-resistant human breast tumors. J. Clin. Oncol., 10: 990-994, 1992.
16. Wolf, D. M., Langan-Fahey, S. M., Parker, C. P., McCague, R., and Jordan, V. C. Investigation of the mechanism of tamoxifen stimulated breast tumor growth with non-isomerizable analogs of tamoxifen and its metabolites. J. Natl. Cancer Inst., 85: 806-812, 1993.
17. Fuqua, S. A. W., Chamness, G. C., and McGuire, W. L. Estrogen receptor mutations in breast cancer. J. Cell. Biochem., 51: 135-139, 1993.
18. Miksicek, R. J. Steroid receptor variants and their potential role in cancer. Semin. Cancer Biol., 5: 369-379, 1994.
19. Daffada, A. A. I., Johnston, S. R. D., Smith, I. E., Detre, S., King, N., and Dowsett, M. Exon 5 deletion variant estrogen receptor messenger RNA expression in relation to tamoxifen resistance and progesterone receptor/pS2 status in human breast cancer. Cancer Res., 55: 288-293, 1995.
20. Karnik, P. S., Kulkarni, S., Liu, X. P., Budd, G. T., and Bukowski, R. M. Estrogen receptor mutations in tamoxifen resistant breast cancer. Cancer Res., 54: 349-353, 1994.
21. Fuqua, S. A. W., Fitzgerald, S. D., Chamness, G. C., Tandon, A. K., McDonnell, D. P., Nawaz, Z., O'Malley, B. W., and McGuire, W. L. Variant human breast tumor estrogen receptor with constitutive transcriptional activity. Cancer Res., 51: 105-109, 1991.
22. Fuqua, S. A. W., Fitzgerald, S. D., Allred, D. C., Elledge, R. M., Nawaz, Z., McDonnell, D. P., O'Malley, B. W., Greene, G. L., and McGuire, W. L. Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors. Cancer Res., 52: 483-486, 1992.
23. Fuqua, S. A., Allred, D. C., Elledge, R. M., Krieg, S. L., Benedix, M. G., Nawaz, Z., O'Malley, B. W., Greene, G. L., and McGuire, W. L. The ER-positive/PgR-negative breast cancer phenotype is not associated with mutations within the DNA binding domain. Br. Cancer Res. Treal., 26: 191-202, 1993.
24. Fuqua, S. A. W., and Wolf, D. M. Molecular aspects of estrogen receptor variants in breast cancer. Breast Cancer Res. Treat., 35: 233-241, 1995.
25. Miksicek, R., Lei, Y., and Wang, Y. Exon skipping gives rise to alternatively spliced forms of the estrogen receptor in breast tumor cells. Breast Cancer Res. Treat., 26: 163-174, 1993.
26. Wang, Y., and Miksicek, R. J. Identification of a dominant negative form of the human estrogen receptor. Mol. Endocrinol., 5: 1707-1715, 1991.
27. Leygue, E., Huang, A., Murphy, L. C., and Watson, P. H. Prevalence of estrogen receptor variant messenger RNAs in human breast cancer. Cancer Res., 56: 4324-4327, 1996.
28. Ishioka, C., Frebourg, T., Yan, Y., Vidal, M., Friend, S., Schmidt, S., and Iggo, R. Screening patients for heterozygous p53 mutations using a functional assay in yeast. Nat. Genet., 5: 124-129, 1993.
29. Metzger, D., White, J. H., and Chambon, P. The human estrogen receptor functions in yeast. Nature (Lond.), 334: 31-36, 1988.
30. Greene, G. L., Gilna, P., Waterfield, M., Baker, A., Hort, Y., and Shine, J. Sequence and expression of human estrogen receptor complementary DNA. Science (Washington DC), 231: 1150-1154, 1986.
31. Vidal, M., and Gaber, R. F. Selectable marker replacement in Saccharomyces cerevisiae. Yeast, 10: 141-149, 1994.
32. Guthrie, C., and Fink, G. R. Guide to yeast genetics and molecular biology. Methods Enzymol., 194: 1991.
33. Klebe, R. J., Harris, J. V., Sharp, Z. D., and Douglas, M. G. A general method for polyethylene-glycol-induced genetic transformation of bacteria and yeast. Gene (Amst.), 25: 333-341, 1983.
34. Hoffman, C. S., and Winston, F. A ten minute DNA preparation from yeast efficiently releases autonomous plasmids for transformation of Escherichia coli. Gene (Amst.), 57: 267-272, 1987.
35. Ma, H., Kunes, S., Schatz, P. J., and Botstein, D. Plasmid construction by homologous recombination in yeast. Gene (Amst.), 58: 201-216, 1487.
36. Metzger, D., Losson, R., Bornert, J-M., Lemoine, Y., and Chambon, P. Promoter specificity of the two transcriplional activation functions of the human oestrogen receptor in yeast. Nucleic Acids Res., 20: 2813-2817, 1992.
37. Flaman, J., Frebourg, T., Moreau, V., Charbonnier, F., Martin, C., Ishioka, C., Friend, S. H., and Iggo, R. A rapid PCR fidelity assay. Nucleic Acids Res., 15: 3259-3260, 1994.
38. Savouret, J. F., Bailly, A., Misrahi, M., Rauch, C., Redeuith, G., Chauchereau, A., and Milgrom, E. Characterization of the hormone responsive element involved in the regulation of the progesterone receptor gene. EMBO J., 10: 1875-1883, 1991.
39. Berry, M., Metzger, D., and Chambon, P. Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen. EMBO J., 9: 2811-2818, 1990.
40. Wrenn, C. K., and Katzenellenbogen, B. S. Structure-function analysis of the hormone binding domain of the human estrogen receptor by region-specific mutagenesis and phenotypic screening in yeast. J. Biol. Chem., 268: 24089-24098, 1993.
41. Pfeffer, U., Fecarotta, E., Castagnetta, L., and Vidali, G. Estrogen receptor variant messenger RNA lacking exon 4 in estrogen-responsive human breast cancer lines. Cancer Res., 53: 741-743, 1993.
42. Zang, Q-X., Borg, A., and Fuqua, S. A. W. An exon 5 deletion variant of the estrogen receptor frequently coexpressed with wild-type estrogen receptor in human breast cancer. Cancer Res., 53: 5882-5884, 1993.
43. Koehorst, S. A. G., Jacobs, H. M., Thijssen, J. H. H., and Blankenstein, M. A. Wild-type and alternatively spliced estrogen receptor messenger RNA in human meningioma tissue and MCF-7 breast cancer cells. J. Steroid Biochem. Mol. Biol., 45: 227-233, 1993.
44. Pfeffer, U., Fecarotta, E., Arena, G., Forlani, A., and Vidali, G. Alternative splicing of the estrogen receptor primary transcript normally occurs in estrogen receptor positive tissues and cell lines. J. Steroid Biochcm. Mol. Biol., 56: 99-105, 1996.
45. Fawell, S. E., Lees, J. A., White, R., and Parker, M. G. Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor. Cell, 60: 953-962, 1990.
46. Schwabe, J. W., Chapman, L., Finch, J. T., and Rhodes, D. The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: how receptors discriminate between their response elements. Cell. 75: 567-578, 1993.
47. Metzger, D., Ali, S., Bornert, J-M., and Chambon, P. Characterization of the aminoterminal transcriptional activation function of the human estrogen receptor in animal and yeast cells. J. Biol. Chem., 270: 9535-9542, 1995.
48. Pfeffer, U., Fecarotta, E., and Vidali, G. Coexpression of multiple estrogen receptor variant messenger RNAs in normal and neoplastic breast tissues and in MCF-7 cells. Cancer Res., 55: 2158-2165, 1995.
49. Leygue, E. R., Watson, P. H., and Murphy, L. C. Estrogen receptor variants in normal human mammary tissue. J. Natl. Cancer Inst., 88: 284-290, 1996.